Hydrazine (antidepressant)

Hydrazine (antidepressant)

Hydrazine is a chemical compound that has been used in the treatment of depression. It is classified as a monoamine oxidase inhibitor (MAOI), a type of antidepressant that works by increasing the levels of certain chemicals in the brain.

History

Hydrazine was first synthesized in the 19th century and was initially used in rocket fuel and other industrial applications. Its potential as an antidepressant was discovered in the mid-20th century, and it was one of the first MAOIs to be used in the treatment of depression.

Mechanism of Action

As an MAOI, hydrazine works by inhibiting the action of an enzyme called monoamine oxidase. This enzyme is responsible for breaking down several neurotransmitters in the brain, including serotonin, norepinephrine, and dopamine. By inhibiting this enzyme, hydrazine increases the levels of these neurotransmitters in the brain, which can help to alleviate the symptoms of depression.

Side Effects

Like all antidepressants, hydrazine can cause a number of side effects. These can include nausea, dizziness, insomnia, and dry mouth. In rare cases, it can also cause more serious side effects such as hypertension or serotonin syndrome.

Interactions

Hydrazine can interact with a number of other medications, including other antidepressants, antipsychotics, and certain types of pain medication. It is therefore important that patients inform their doctor of any other medications they are taking before starting treatment with hydrazine.

See Also

• Monoamine oxidase inhibitor
• Depression
• Antidepressant

References

This article is a stub related to pharmacology. You can help WikiMD by expanding it!